SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001485003-22-000047
Filing Date
2022-04-28
Accepted
2022-04-28 08:08:59
Documents
5
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A sesn2022definitiveproxysta.htm DEF 14A 539852
2 image.jpg GRAPHIC 6288
3 logoa05.jpg GRAPHIC 7341
4 proxycard1finaldef14-jpeg.jpg GRAPHIC 113668
5 proxycard2finaldef14-jpeg.jpg GRAPHIC 77422
  Complete submission text file 0001485003-22-000047.txt   823425
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36296 | Film No.: 22862341
SIC: 2834 Pharmaceutical Preparations